Predictors of start of different antidepressants in patient charts among patients with depression. - Wikidata - wikimedia - TriplyDB

Predictors of start of different antidepressants in patient charts among patients with depression.

Predictors of start of different antidepressants in patient charts among patients with depression.

http://www.wikidata.org/entity/Q37050214

about

Comparing the Effects of Sertraline with Duloxetine for Depression Severity and Symptoms: A Double-Blind, Randomized Controlled Trial.Demographic and clinical factors associated with different antidepressant treatments: a retrospective cohort study design in a UK psychiatric healthcare setting

P2860

Q48058387-001F39FB-C5FB-4E51-A9E8-E9CD2277AE79 Q58763102-319C7BEA-62C0-44C3-866D-9D6DEACC5F43

P2860

Predictors of start of different antidepressants in patient charts among patients with depression.

http://www.wikidata.org/entity/Q37050214

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2015

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Predictors of start of differe ...... mong patients with depression.

@en

Predictors of start of differe ...... mong patients with depression.

@nl

type

label

Predictors of start of differe ...... mong patients with depression.

@en

Predictors of start of differe ...... mong patients with depression.

@nl

prefLabel

Predictors of start of differe ...... mong patients with depression.

@en

Predictors of start of differe ...... mong patients with depression.

@nl

P1433

Q37050214-6B303C47-9021-43D3-9646-EF6FB24F54A4

P1476

Q37050214-45B21F45-C233-44FF-839B-9BE759973661

P2093

Q37050214-1E5366B5-5673-47A5-8A50-D415CEA7B989

Q37050214-96582BB3-48C7-4E51-82B2-8B4D705A6444

Q37050214-C112E401-F903-47B5-A360-96622687A34D

Q37050214-C7B85C83-902D-44A2-B639-C50277B06974

Q37050214-ED941543-21A6-495E-9EB6-A15C59702C0D

Q37050214-F32BD4AF-8035-47FC-AD15-41C39B3BD9EA

P2860

Q37050214-06F4B701-4A8D-4283-B251-8F870F8A3932

Q37050214-16918C00-9418-46E2-9915-07EC48DA60F5

Q37050214-20168DBC-E065-45F3-BC5B-EAD0740FD0BD

Q37050214-2901FEB0-7165-4ACB-9909-1BFB83A9A10B

Q37050214-662E3567-9919-48CB-AB37-89E800DF9DBD

Q37050214-742C24A0-BE29-44DD-ACEC-DAB1EC0A772B

Q37050214-799A7A20-37AD-49A0-BAF0-9C6A24207FDA

Q37050214-805AAFF5-C4C7-499C-AE2C-EDB16C1C82FE

Q37050214-AF252E41-F35B-4ED4-BA10-19D0CEBD55FA

Q37050214-C1B70281-8C2A-4750-AD7D-4961071AA1E3

P304

Q37050214-99166291-BD84-499C-BF60-6E65F3D529F6

P31

Q37050214-09BB83CE-C79D-43FF-85C8-5153E54F081D

P356

Q37050214-9B820A45-27E6-42A5-B4BB-C6039FCD7256

P433

Q37050214-7C420B36-1700-44BB-947A-D7C1DDBD6C7F

P478

Q37050214-4F784CCE-189F-44FD-BEDF-904ACDF0F8B4

P50

Q37050214-B0FDB3B4-8CE1-4B91-8BFB-53A394711A91

P577

Q37050214-BF27624D-E435-4F67-B4E7-7C6051E5BF18

P5875

Q37050214-A388F920-4C29-4D2F-8878-CBDA9E3D86C0

P698

Q37050214-EAC4D894-09C4-44E2-A41B-B560C0B287AF

P932

Q37050214-10C6141A-FAB8-42B9-8A07-DF2AE867E871

P356

JMCP.2015.21.5.424

P1433

Journal of Managed Care & Specialty Pharmacy

P1476

Predictors of start of differe ...... mong patients with depression.

@en

P2093

Clare M Stano

http://www.w3.org/2001/XMLSchema#string

Dara Ganoczy

http://www.w3.org/2001/XMLSchema#string

Hae Mi Choe

http://www.w3.org/2001/XMLSchema#string

Heather Walters

http://www.w3.org/2001/XMLSchema#string

Hyungjin Myra Kim

http://www.w3.org/2001/XMLSchema#string

Kara Zivin

http://www.w3.org/2001/XMLSchema#string

P2860

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Effects of mirtazapine on sleep polygraphic variables in major depression.

Validation of key behaviourally based mental health diagnoses in administrative data: suicide attempt, alcohol abuse, illicit drug abuse and tobacco use.

Predictors of alternative antidepressant agent initiation among U. S. veterans diagnosed with depression.

Antidepressants and the risk of suicidal behaviors.

Sildenafil treatment of women with antidepressant-associated sexual dysfunction: a randomized controlled trial.

Antidepressant-associated sexual dysfunction: impact, effects, and treatment.

SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.

Antidepressant agents and suicide death among US Department of Veterans Affairs patients in depression treatment.

Enhanced identification of eligibility for depression research using an electronic medical record search engine

P304

424-430

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18553/JMCP.2015.21.5.424

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

Marcia Valenstein

P577

2015-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276073195

http://www.w3.org/2001/XMLSchema#string

P698

25943003

http://www.w3.org/2001/XMLSchema#string

P932

4926260

http://www.w3.org/2001/XMLSchema#string